- Home
- ARCT vs OLP Comparison
ARCT vs OLP Comparison
Compare ARCT & OLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- OLP
- Stock Information
- Founded
- ARCT 2013
- OLP 1982
- Country
- ARCT United States
- OLP United States
- Employees
- ARCT N/A
- OLP N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- OLP Real Estate Investment Trusts
- Sector
- ARCT Health Care
- OLP Real Estate
- Exchange
- ARCT Nasdaq
- OLP Nasdaq
- Market Cap
- ARCT 487.0M
- OLP N/A
- IPO Year
- ARCT N/A
- OLP N/A
- Fundamental
- Price
- ARCT $15.88
- OLP $25.75
- Analyst Decision
- ARCT Strong Buy
- OLP Strong Buy
- Analyst Count
- ARCT 8
- OLP 1
- Target Price
- ARCT $61.00
- OLP $28.00
- AVG Volume (30 Days)
- ARCT 405.9K
- OLP 46.6K
- Earning Date
- ARCT 03-06-2025
- OLP 03-04-2025
- Dividend Yield
- ARCT N/A
- OLP 7.06%
- EPS Growth
- ARCT N/A
- OLP 51.11
- EPS
- ARCT N/A
- OLP 1.63
- Revenue
- ARCT $160,399,000.00
- OLP $89,142,000.00
- Revenue This Year
- ARCT $7.33
- OLP N/A
- Revenue Next Year
- ARCT $4.71
- OLP $4.71
- P/E Ratio
- ARCT N/A
- OLP $15.65
- Revenue Growth
- ARCT N/A
- OLP N/A
- 52 Week Low
- ARCT $14.30
- OLP $19.75
- 52 Week High
- ARCT $45.00
- OLP $30.45
- Technical
- Relative Strength Index (RSI)
- ARCT 41.74
- OLP 42.45
- Support Level
- ARCT $16.03
- OLP $25.08
- Resistance Level
- ARCT $17.95
- OLP $25.93
- Average True Range (ATR)
- ARCT 1.29
- OLP 0.53
- MACD
- ARCT -0.07
- OLP 0.09
- Stochastic Oscillator
- ARCT 10.29
- OLP 52.99
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.